Literature DB >> 30062677

Germline mosaicism is a pitfall in the diagnosis of "sporadic" X-linked Alport syndrome.

Takayuki Okamoto1, Kandai Nozu2, Kazumoto Iijima2, Tadashi Ariga3.   

Abstract

Approximately 80% of patients with Alport syndrome have X-linked Alport syndrome (XLAS), which is caused by mutations in the type IV collagen alpha 5 gene (COL4A5). In patients with XLAS, approximately 10-15% of COL4A5 mutations occur as spontaneous events. Here, we describe maternal germline mosaicism in a family of XLAS patients. Since our patient's parents showed normal urinary findings without COL4A5 mutation using genomic DNA isolated from peripheral leukocytes, the patient was initially diagnosed with "sporadic" XLAS. However, genetic analysis of the patient's sister with microscopic hematuria identified the same COL4A5 heterozygous mutation. Therefore, we concluded that our patient and the sister had XLAS caused by maternal germline mosaicism, not "sporadic" XLAS. Our case suggests that "sporadic" XLAS may in some patients be caused by the transmission of an abnormal allele from either parent with germline mosaicism in COL4A5. Germline mosaicism is thought to be rare, but we should consider that even asymptomatic parents of "sporadic" XLAS patients could carry a somatic and/or germline mosaicism. More cautious genetic counseling is advisable for all "sporadic" XLAS patients. Furthermore, urinalysis screening of "sporadic" XLAS patients' siblings is also important to enable an earlier detection of parental germline mosaicism.

Entities:  

Keywords:  Genetic counseling; Germline mosaicism; Isolated; XLAS

Mesh:

Substances:

Year:  2018        PMID: 30062677     DOI: 10.1007/s40620-018-0518-y

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  12 in total

1.  Somatic mosaicism associated with a mild Alport syndrome phenotype.

Authors:  K E Plant; E Boye; P M Green; D Vetrie; F A Flinter
Journal:  J Med Genet       Date:  2000-03       Impact factor: 6.318

2.  Mosaicism in Alport syndrome with genetic counselling.

Authors:  M Bruttini; F Vitelli; I Meloni; G Rizzari; M D Volpe; G Mazzucco; M D Marchi; A Renieri
Journal:  J Med Genet       Date:  2000-09       Impact factor: 6.318

3.  Deep sequencing detects very-low-grade somatic mosaicism in the unaffected mother of siblings with nemaline myopathy.

Authors:  Satoko Miyatake; Eriko Koshimizu; Yukiko K Hayashi; Kazushi Miya; Masaaki Shiina; Mitsuko Nakashima; Yoshinori Tsurusaki; Noriko Miyake; Hirotomo Saitsu; Kazuhiro Ogata; Ichizo Nishino; Naomichi Matsumoto
Journal:  Neuromuscul Disord       Date:  2014-04-24       Impact factor: 4.296

4.  Female X-linked Alport syndrome with somatic mosaicism.

Authors:  Kana Yokota; Kandai Nozu; Shogo Minamikawa; Tomohiko Yamamura; Keita Nakanishi; Hisashi Kaneda; Riku Hamada; Yoshimi Nozu; Akemi Shono; Takeshi Ninchoji; Naoya Morisada; Shingo Ishimori; Junya Fujimura; Tomoko Horinouchi; Hiroshi Kaito; Koichi Nakanishi; Ichiro Morioka; Mariko Taniguchi-Ikeda; Kazumoto Iijima
Journal:  Clin Exp Nephrol       Date:  2016-10-31       Impact factor: 2.801

Review 5.  Clinical impact of somatic mosaicism in cases with small supernumerary marker chromosomes.

Authors:  T Liehr; E Klein; K Mrasek; N Kosyakova; R S Guilherme; N Aust; C Venner; A Weise; A B Hamid
Journal:  Cytogenet Genome Res       Date:  2012-12-29       Impact factor: 1.636

Review 6.  Familial hematuria: A review.

Authors:  Pavlína Plevová; Josef Gut; Jan Janda
Journal:  Medicina (Kaunas)       Date:  2017-01-31       Impact factor: 2.430

7.  Somatic mosaicism and variant frequency detected by next-generation sequencing in X-linked Alport syndrome.

Authors:  Xue Jun Fu; Kandai Nozu; Hiroshi Kaito; Takeshi Ninchoji; Naoya Morisada; Koichi Nakanishi; Norishige Yoshikawa; Hiromi Ohtsubo; Natsuki Matsunoshita; Naohiro Kamiyoshi; Chieko Matsumura; Nobuaki Takagi; Kohei Maekawa; Mariko Taniguchi-Ikeda; Kazumoto Iijima
Journal:  Eur J Hum Genet       Date:  2015-05-27       Impact factor: 4.246

8.  Somatic mosaicism for a mutation of the COL4A5 gene is a cause of mild phenotype male Alport syndrome.

Authors:  Rafal Przybyslaw Krol; Kandai Nozu; Koichi Nakanishi; Kazumoto Iijima; Yasuhiro Takeshima; Xue Jun Fu; Yoshimi Nozu; Hiroshi Kaito; Kyoko Kanda; Masafumi Matsuo; Norishige Yoshikawa
Journal:  Nephrol Dial Transplant       Date:  2008-03-10       Impact factor: 5.992

9.  Next generation sequencing as a useful tool in the diagnostics of mosaicism in Alport syndrome.

Authors:  Sonja Beicht; Gertrud Strobl-Wildemann; Sabine Rath; Oliver Wachter; Martin Alberer; Elke Kaminsky; Lutz T Weber; Tanja Hinrichsen; Hanns-Georg Klein; Julia Hoefele
Journal:  Gene       Date:  2013-05-31       Impact factor: 3.688

Review 10.  Unrevealed mosaicism in the next-generation sequencing era.

Authors:  Marzena Gajecka
Journal:  Mol Genet Genomics       Date:  2015-10-19       Impact factor: 3.291

View more
  3 in total

1.  Identification of paternal germline mosaicism by MicroSeq and targeted next-generation sequencing.

Authors:  Congling Dai; Dehua Cheng; Weina Li; Sicong Zeng; Guangxiu Lu; Qianjun Zhang
Journal:  Mol Genet Genomic Med       Date:  2020-07-09       Impact factor: 2.183

2.  Detection of Very Low-Level Somatic Mosaic COL4A5 Splicing Variant in Asymptomatic Female Using Droplet Digital PCR.

Authors:  Haiyue Deng; Yanqin Zhang; Jie Ding; Fang Wang
Journal:  Front Med (Lausanne)       Date:  2022-03-07

3.  Low frequency of parental mosaicism in de novo COL4A5 mutations in X-linked Alport syndrome.

Authors:  Ole Magnus Bjorgaas Helle; Torkild Høieggen Pedersen; Lilian Bomme Ousager; Mads Thomassen; Jens Michael Hertz
Journal:  Mol Genet Genomic Med       Date:  2020-08-18       Impact factor: 2.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.